Tactical Resources (TREO) Director Basi Kuljit Singh Receives Award
$TREO · Tactical Resources Corp.Research Summary
AI-generated summary of this SEC filing
Tactical Resources (TREO) Director Basi Kuljit Singh Receives Award
What Happened Basi Kuljit Singh, a director of Tactical Resources Corp. (TREO), received a grant of 32,500 performance stock units (PRSUs) reported on Form 4 for the period date 2026-08-20. The award is reported at $0.00 (derivative award); no cash was exchanged. The PRSUs are contingent rights to receive common shares if specified conditions are met.
Key Details
- Transaction date: 2026-08-20 (reported on Form 4 filed 2026-08-24). Transaction type: A (award/grant). Report was timely (filed within the Form 4 deadline).
- Amount: 32,500 PRSUs; reported price $0.00 (derivative grant).
- Vesting/conditions (Footnote F1): Each PRSU converts to one common share upon the earlier of (i) achieving pre-set stock price targets or (ii) a change of control, and subject to continued employment through payment. Vesting: one-third at a $50 VWAP Stock Price Level, one-third at $60, and one-third at $70. Unvested PRSUs are forfeited after seven years from grant.
- Reverse split (Footnote F2): The filing reflects a 1-for-4 reverse stock split effective 08/20/2026; reported share counts incorporate that adjustment.
- Other footnotes (F3–F5): The filing also includes details about a separate convertible debenture (maturity, interest, conversion into Units and accompanying warrants) — not directly tied to this PRSU grant but included in the filing.
- Shares owned after the transaction: not specified in the provided transaction details (see the full Form 4 for total holdings).
Context This was a compensation award (derivative/contingent grant), not an open-market buy or sale. PRSUs only become actual common shares if performance or change-of-control conditions are met and the director remains employed; until then they carry no immediate cash value or voting power. Such grants are common for aligning executive/director pay with company performance and should not be read as an immediate insider purchase or sale.